Aviram, Michael
The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism
Part 1. The Bert La Du Memorial Lecture
1. Paraoxonases: An Historical Perspective
C.E. Furlong
Part 2. PONs and Atherosclerosis
2. Glucose Inactivates Paraoxonase 1 (PON1) and Displaces it from High Density Lipoprotein (HDL) to a Free PON1 Form
Mira Rosenblat, Orly Sapir, Michael Aviram
3. Paraoxonase-1 and Cardiovascular Disease
B. Mackness, M.I. Mackness
4. Oxidative Stress & Antioxidants and PON1 in Health and Disease
Eser Yildirim Sozmen, Ferhan Girgin Sagin, Meral Kayikcioglu, Bulent Sozmen
5. D-4F Increases Paraoxonase 1 Activity in HDL
Greg Hough
6. Paraoxonase 1 (PON1), A Junction Between the Metabolisms of Homocysteine and Lipids
H. Jakubowski
7. The Role of PON2 and PON3 in Atherosclerosis and Related Traits
N. Bourquard, D.M. Shih, C.J. Ng, N. Villa-Garcia, K. Nakamura, D.A. Stoltz, E. Ozer, V. Grijalva, N. Rozengurt, S.Y. Hama, J. Zabner, M. Navab, A.M. Fogelman, S.T. Reddy
8. Paraoxonase 1 and Postprandial Lipemia
A. Alipour, B. Coll, A.P. Rietveld, J. Marsillach, J. Camps, J. Joven, J.W.F. Elte, M. Castro Cabezas
9. PON1 Genotypes and Coronary Heart Disease
M. Roest, H.A.M. Voorbij
Part 3. PON1 Structure
10. Human Paraoxonase I: A Potential Bioscavenger of Organophosphorus Nerve Agents
David T. Yeung, David E. Lenz, Douglas M. Cerasoli
11. Stabilisation of Active Form of Natural Human PON1 Requires HPBP
D. Rochu, E. Chabriere, M. Elias, F. Renault, C. Clery-Barraud, P. Masson
Part 4. PONs in Disease other than Atherosclerosis
12. Paraoxonase-1 in Chronic Liver Diseases, Neurological Diseases and HIV Infection
J. Marsillach, S. Parra, N. Ferré, B. Coll, C. Alonso-Villaverde, J. Joven, J. Camps
13. Age-Related Alterations in PON1
I. Seres, T. Fulop, G. Paragh, A. Khalil
Part 5. PON and Toxicology
14. Paraoxonase (PON1) and Organophosphate Toxicity
L.G. Costa, T.B. Cole, K.L. Jansen, C.E. Furlong
15. Implications of Paraoxonase-1 (PON1) Activity and Polymorphisms on Biochemical and Clinical Outcomes in Workers Exposed to Pesticides
A.F. Hernández, O. López, G. Pena, J.L. Serrano, T. Parrón, L. Rodrigo, F. Gil, A. Pla
Part 6. PON-Genetics and Regulation
16. Transcriptional Regulation of the Paraoxonase Genes
S.P. Deakin, R.W. James
17. Effect of Lipid Lowering Medications on PON1
G. Paragh, M. Harangi, I. Seres
18. The Functional Consequences of Polymorphisms in the Human PON1 Gene
C.E. Furlong, R.J Richter, W.-F. Li, V.H. Brophy, C. Carlson, M. Rieder, D. Nickerson, L.G. Costa, J. Ranchalis, A.J. Lusis, D.M. Shih, A. Tward, G.P. Jarvik
19. Dietary Modulation of Paraoxonase-1 Activity and Concentration in Humans
C. Dalgård
Part 7. PONs Biochemistry
20. PONs’ Natural Substrates – The Key for their Physiological Roles
D.I. Draganov, J.F. Teiber
21. Paraoxonases, Quorum Sensing, And Pseudomonas Aeruginosa
D.A. Stoltz, E.A. Ozer, J. Zabner
DRM-restrictions
Printing: not available
Clipboard copying: not available
Keywords: MEDICAL / Public Health MED078000
- Author(s)
- Aviram, Michael
- Mackness, Bharti
- Mackness, Mike
- Paragh, György
- Publisher
- Springer
- Publication year
- 2008
- Language
- en
- Edition
- 1
- Category
- Medicine, Health Care, Mode
- Format
- Ebook
- eISBN (PDF)
- 9781402065613